TriangleNCT00084682 · OUTCOME
Time to Progression
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- Not reported
- Unit
- Not reported
- Interval / dispersion
- Not reported
- Time frame
- Up to 2 years
What was measured
All time to event endpoints will be evaluated using Kaplan Meier estimates and survival curves will be generated based on these estimates.
Analysis population: Data not collected. As the first stage goal of 8 patients with disease control was not achievable, further follow up was not done.
Groups in this outcome
Treatment (Romidepsin)
Patients receive FR901228 (depsipeptide) IV at 13 mg/m2 over 4 hours on days 1, 8, and 15. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity. romidepsin: Given IV
| Group | Source count |
|---|---|
| Treatment (Romidepsin) | 0 |
Reported measurements
No numerical measurement classes were posted for this outcome. Missing is not zero.
Complete source fields
- denoms
- counts
- group Id
- OG000
- value
- 0
- units
- Participants
- description
- All time to event endpoints will be evaluated using Kaplan Meier estimates and survival curves will be generated based on these estimates.
- groups
- description
- Patients receive FR901228 (depsipeptide) IV at 13 mg/m2 over 4 hours on days 1, 8, and 15. Courses repeat every 28 days in the absence of disease progression or unacceptable toxicity. romidepsin: Given IV
- id
- OG000
- title
- Treatment (Romidepsin)
- population Description
- Data not collected. As the first stage goal of 8 patients with disease control was not achievable, further follow up was not done.
- reporting Status
- POSTED
- time Frame
- Up to 2 years
- title
- Time to Progression
- type
- SECONDARY
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice